In your trust, how many patients with a diagnosis of Hidradenitis Suppurativa* (HS) have been treated in the last 12 months [latest available]?
Of these patients how many have been treated with the following;
Adalimumab
Etanercept
Infliximab
Infliximab Biosimilar
Ustekinumab